Stableford Capital II’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,205
| Closed | -$422K | – | 149 |
|
|
2025
Q4 | $422K | Hold |
1,205
| – | – | 0.15% | 130 |
|
|
2025
Q3 | $389K | Hold |
1,205
| – | – | 0.14% | 126 |
|
|
2025
Q2 | $348K | Sell |
1,205
-3,051
| -72% | -$1.23M | 0.13% | 115 |
|
|
2025
Q1 | $1.81M | Buy |
4,256
+1,949
| +84% | +$782K | 0.76% | 31 |
|
|
2024
Q4 | $851K | Sell |
2,307
-22
| -0.9% | -$9.21K | 0.34% | 90 |
|
|
2024
Q3 | $1.17M | Sell |
2,329
-3
| -0.1% | -$1.6K | 0.47% | 63 |
|
|
2024
Q2 | $1.21M | Buy |
2,332
+8
| +0.3% | +$4.23K | 0.48% | 55 |
|
|
2024
Q1 | $1.21M | Buy |
2,324
+4
| +0.2% | +$1.99K | 0.48% | 47 |
|
|
2023
Q4 | $1.12M | Buy |
2,320
+27
| +1% | +$12.5K | 0.48% | 41 |
|
|
2023
Q3 | $1.03M | Sell |
2,293
-1
| -0% | -$454 | 0.48% | 33 |
|
|
2023
Q2 | $1.07M | Buy |
+2,294
| New | +$1.06M | 0.47% | 36 |
|
|
2023
Q1 | – | Sell |
-2,317
| Closed | -$1.09M | – | 93 |
|
|
2022
Q4 | $1.09M | Sell |
2,317
-11
| -0.5% | -$5.58K | 0.59% | 30 |
|
|
2022
Q3 | $1.19M | Sell |
2,328
-11
| -0.5% | -$5.26K | 0.58% | 35 |
|
|
2022
Q2 | $1.11M | Sell |
2,339
-152
| -6% | -$75.2K | 0.51% | 35 |
|
|
2022
Q1 | $1.28M | Sell |
2,491
-3,022
| -55% | -$1.38M | 0.54% | 41 |
|
|
2021
Q4 | $2.48M | Buy |
5,513
+390
| +8% | +$164K | 1.04% | 24 |
|
|
2021
Q3 | $2M | Sell |
5,123
-94
| -2% | -$35.7K | 1.02% | 24 |
|
|
2021
Q2 | $1.99M | Buy |
5,217
+154
| +3% | +$58.9K | 0.95% | 29 |
|
|
2021
Q1 | $1.82M | Buy |
5,063
+2,884
| +132% | +$927K | 0.92% | 31 |
|
|
2020
Q4 | $700K | Buy |
+2,179
| New | +$669K | 0.41% | 62 |
|
|
2019
Q2 | – | Sell |
-5,483
| Closed | -$1.57M | – | 91 |
|
|
2019
Q1 | $1.57M | Sell |
5,483
-4,293
| -44% | -$1.24M | 1.31% | 17 |
|
|
2018
Q4 | $2.57M | Sell |
9,776
-1,248
| -11% | -$343K | 2.73% | 8 |
|
|
2018
Q3 | $3.02M | Buy |
11,024
+25
| +0.2% | +$6.49K | 1.99% | 15 |
|
|
2018
Q2 | $2.62M | Sell |
10,999
-102
| -0.9% | -$23.6K | 1.7% | 16 |
|
|
2018
Q1 | $2.44M | Buy |
11,101
+293
| +3% | +$68.8K | 1.71% | 16 |
|
|
2017
Q4 | $2.43M | Buy |
10,808
+536
| +5% | +$114K | 1.64% | 17 |
|
|
2017
Q3 | $1.95M | Buy |
10,272
+4,500
| +78% | +$856K | 1.42% | 19 |
|
|
2017
Q2 | $1.09M | Buy |
5,772
+169
| +3% | +$30.4K | 0.87% | 34 |
|
|
2017
Q1 | $927K | Buy |
+5,603
| New | +$891K | 0.8% | 36 |
|
Other funds holding ELV
VCM
VPM
Stableford Capital II's ELV Position: Q1 2026 in Review
Stableford Capital II sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 1,205 shares — an estimated $422K sold.
Stableford Capital II first reported a position in ELV in Q1 2017 and held it in 29 quarters. The position peaked at $3.02M in Q3 2018. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- Stableford Capital II reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
- Stableford Capital II sold 1,205 Elevance Health shares in Q1 2026, an estimated $422K.
- Stableford Capital II first reported a position in Elevance Health in Q1 2017 and held it in 29 quarters.
- Stableford Capital II's Elevance Health position peaked at $3.02M in Q3 2018.
- 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on Stableford Capital II's 13F filing for Q1 2026, filed 6 Apr 2026.